{
    "Trade/Device Name(s)": [
        "Immunalysis Tramadol Urine Enzyme Immunoassay",
        "Immunalysis Tramadol Urine Controls",
        "Immunalysis Tramadol Urine Calibrators"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K141803",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120761"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "December 30, 2014",
    "Summary Letter Received Date": "January 2, 2015",
    "Submission Date": "February 2, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Tramadol"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Beckman Coulter AU 400e"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Qualitative analysis",
        "Semi-quantitative analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Tramadol Urine Enzyme Immunoassay, controls, and calibrators for qualitative and semi-quantitative detection of Tramadol in urine using automated clinical chemistry analyzers",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of Tramadol in human urine using automated clinical chemistry analyzers; preliminary test requiring confirmatory methods for final result",
    "fda_folder": "Toxicology"
}